GeneDx Holdings (WGS) Long-Term Deferred Tax (2020 - 2021)

GeneDx Holdings (WGS) posted quarterly Long-Term Deferred Tax of $426000.0 for Q1 2021, up 954.46% quarter-over-quarter from $40400.0 in Q4 2020.

GeneDx Holdings (WGS) Long-Term Deferred Tax (2020 - 2021) Analysis & Trends

GeneDx Holdings (WGS) has reported Long-Term Deferred Tax for 2 consecutive years, with $426000.0 the latest figure, recorded in Q1 2021.

In Q1 2021, Long-Term Deferred Tax changed N/A year-over-year to $426000.0; the TTM figure through Mar 2021 stood at $426000.0 (changed N/A YoY), while the FY2020 annual figure was $40400.0, changed N/A from the prior year.
Long-Term Deferred Tax rose to $426000.0 in Q1 2021 per WGS's latest filing, from $40400.0 in the prior quarter.
Across five years, Long-Term Deferred Tax topped out at $426000.0 in Q1 2021 and bottomed at $12000.0 in Q3 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Thermo Fisher Scientific	213.88 Bn	209.81 Bn	8.34 Bn
2	Danaher	140.65 Bn	136.30 Bn	3.61 Bn
3	Idexx Laboratories	46.02 Bn	45.83 Bn	779.09 Mn
4	Agilent Technologies	39.85 Bn	38.05 Bn	990.00 Mn
5	Iqvia Holdings	39.20 Bn	37.12 Bn	1.44 Bn
6	Natera	38.80 Bn	37.70 Bn	696.04 Mn
7	Illumina	30.11 Bn	28.94 Bn	770.00 Mn
8	Mettler Toledo International	28.66 Bn	28.61 Bn	650.22 Mn
9	Quest Diagnostics	26.24 Bn	25.61 Bn	1.03 Bn
10	GeneDx Holdings	2.08 Bn	1.94 Bn	78.24 Mn

Download Data